$BRZE

Hyman Jonathan sold $282K of BRZE

Hyman Jonathan (Chief Technology Officer) sold 9,413 shares of Braze, Inc. (BRZE) at an average of $29.99 ($28.77–$30.75, $0.28M total) across 3 trades on 2026-08-19 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Hyman Jonathan
Published Aug 21, 2026, 9:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 21, 2026, 9:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BRZE
Neutral
high confidence
Mentioned
$BRZE
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BRZENeutralLow
01

Why it matters

The disclosed sale is small relative to the company's market cap and does not indicate a material shift in insider sentiment.

02

Market read

Minor insider sale with limited trading relevance.

03

What to watch

Potential upcoming corporate actions or compensation plans not disclosed.

Relevance 3/10Novelty 4/10Timing: filing date 2026-08-21

Background

Form 4 filings disclose insider transactions; a CTO sale via a 10b5-1 plan is routine and often pre-scheduled.

Company-level read

Ticker impact

$BRZENeutralHigh confidence
Context

Chief Technology Officer sold 9,413 shares for $282K via a 10b5-1 plan, reducing his stake to 1,195,219 shares.

Expected impact

Limited short-term impact; price likely unchanged.

Evidence & confidence

The sale amount is modest relative to market cap and insider holdings remain substantial.

Market effects

None

None

None

Counterpoint

Insider sale could be interpreted as a lack of confidence, but the 10b5-1 plan suggests pre-arranged execution, not sentiment-driven.

Key entities

  • Braze, Inc.

    Provider of customer engagement platform, ticker BRZE.

  • Hyman Jonathan

    Chief Technology Officer of Braze.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BRZEMedAI 8/10

Why Braze Stock Plummeted This Week

Braze (BRZE) stock fell 25.1% this week despite beating Q2 earnings and revenue estimates, and raising guidance. Revenue grew 26% YoY to $227.2M, and EPS grew 19% YoY to $0.19. The company expects FY sales of $910M-$913M and EPS of $0.64-$0.65. Investors may be concerned about stock-based compensation and event-related costs.

$BRZEMed

Braze, Inc. Q2 2027 Earnings Call Summary

Braze, Inc. reported Q2 2027 earnings, highlighting 112% large customer retention, 600 basis points of operational efficiency improvement, and raised full-year guidance. Growth was driven by the 'Agentic Harness' framework and AWS collaboration. The company expects AI adoption to accelerate, with new tools like Content Optimizer and Decisioning Studio. Braze is investing in sales capacity and addressing AI trust gaps with 'Agentic Standards.'

$BRZEHighAI 8/10

Braze (BRZE) Q2 2027 Earnings Call Transcript

Braze (BRZE) reported Q2 2027 revenue of $227.2M, up 26.2% YoY, with non-GAAP operating income of $22M (9.7% margin). Customer count rose 15% YoY to 2,789, with large customers growing 28% YoY. Guidance for FY2027 revenue is $910M-$913M, with operating income of $75.5M-$76.5M. Management highlighted AI tool adoption and strategic partnerships, including a collaboration with AWS.

$BRZEMed

Braze (BRZE) Posted a Strong Q2. Are Investors Still Cautious?

Braze (BRZE) reported Q2 revenue of $227.2M, up 26.2% YoY, with subscription revenue at $207.7M. Adjusted operating income rose to $22M. The company expanded its AI tools and partnered with AWS. Hedge fund ownership slightly decreased, with FMR as the largest investor. Investors focus on AI ROI and partnership execution.

$BRZEMedAI 8/10

Braze (BRZE) Posts Strong Q2, But Why Is the Stock Falling?

Braze (BRZE) reported Q2 revenue of $227.2M, up 26.2% Y/Y, and adjusted earnings of $0.19 per share, beating estimates. Despite strong results, shares fell 20% due to Q3 earnings guidance below expectations. Full-year revenue outlook raised to $910M-$913M. Hedge fund interest declined slightly, and short interest is 13.72%.

$BRZEHighAI 8/10

Braze (BRZE) Stock Trades Down, Here Is Why

Braze (BRZE) shares fell 18.9% after reporting Q2 2026 results. Revenue grew 26.2% YoY to $227.2M, beating estimates, with improved profitability. However, slower customer growth and lower-than-expected EPS guidance dampened sentiment. Analysts remain bullish, with Raymond James raising its price target to $33.